California Public Employees Retirement System Boosts Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

California Public Employees Retirement System raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 270,883 shares of the biopharmaceutical company’s stock after acquiring an additional 1,123 shares during the […]

Related Keywords

California ,United States ,David Bartel ,Phillip Zamore ,Akshay Vaishnaw ,Thomas Tuschl ,Pushkal Garg ,Ci Investments Inc ,News Ratings For Alnylam Pharmaceuticals Daily ,Guardian Wealth Advisors ,Alta Advisers Ltd ,Ef Hutton Acquisition Co ,Securities Exchange Commission ,Nasdaq ,Alnylam Pharmaceuticals ,Quarter For Alnylam Pharmaceuticals ,Morgan Stanley ,California Public Employees Retirement System ,Alnylam Pharmaceuticals Stock Down ,Harvest Fund Management Co ,Alnylam Pharmaceuticals Profile ,Alnylam Pharmaceuticals Inc ,Get Rating ,Public Employees Retirement System ,Wealth Advisors ,Advisers Ltd ,Fund Management ,Pharmaceuticals Stock Down ,Exchange Commission ,President Akshay Vaishnaw ,Noble Laureate ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,